New Four-Drug attack on tough pancreatic cancer
NCT ID NCT05014776
Summary
This study is testing a combination of four drugs (CRS-207, pembrolizumab, ipilimumab, and tadalafil) to see if it is safe and can help control advanced pancreatic cancer that has spread and has gotten worse after at least one round of prior chemotherapy. It is for adults whose cancer has spread and can be measured on scans. The main goal is to see how many patients' tumors shrink in response to the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21231, United States
Conditions
Explore the condition pages connected to this study.